Search

You searched for "Injection"

911 results found

A phase II dose-ranging study of mirabegron in patients with OAB

1 March 2014 | | URO - Functional / Reconstructive Urology
This was a multinational, multicentre, randomised, double–blind, double-dummy, parallel group placebo- and active- controlled phase II study. The study enrolled 1108 men and women aged 18 and over. The criteria were: patients must have had overactive blader (OAB) symptoms for...
European Urology cover image with Editor's Choice stamp

Prostatic artery embolisation versus sham

7 July 2020 | | URO - Functional / Reconstructive Urology, URO - Uroradiology
Randomised trials with use of sham is uncommon in the surgical literature, which makes this paper more interesting. Many different treatments are available for treating lower urinary tract symptoms / benign prostatic hyperplasia (LUTS / BPH). Prostatic artery embolisation (PAE)...

Prostate Cancer UK warns of over 8,600 ‘missing men’ as referrals drop by 52,000

5 May 2021 | Research & Development, COVID-19
The Covid-19 pandemic has led to around 52,000 (28%) fewer urgent prostate cancer referrals in England alone, according to statistics shared by Prostate Cancer UK. It’s estimated that more than 8,600 fewer men started treatment for...

Male infertility?

18 June 2021 | Research & Development
Diagnose Sperm Oxidative Stress, a major cause of male infertility, using MiOXSYS™

Cutting for the Stone

1 January 2014 | | URO - Technology, URO - Endourology & Stones
In this series of articles I am going to show you some of the exhibits contained in the BAUS Virtual Museum of the History of Urology which is part of the BAUS website ( www.baus.org.uk). In the last article I...

An interview with ChatGPT (3.5)

4 May 2023 | | URO - Technology
For this month’s Digital Review I explored the hype surrounding Chat Generative Pre-trained Transformer (GPT) from Open AI. The free version is still available at https://chat.openai.com/chat (ChatGPT 3.5) and was used in this article. At the time of writing this...

New distributor appointed for Urethrotech UCD

4 November 2019 | Company Profiles
Urethrotech® Ltd., who develop innovative solutions for safe lower urinary tract instrumentation, have appointed Pennine Healthcare as their exclusive distributor in the United Kingdom and the Republic of Ireland.

An effective new solution for chronic pelvic pain patients

4 March 2022 | Research & Development
The Feel Free Programme is a safe, effective innovation which addresses the overwhelming caseload pressure on clinics because patients can start right now...

New senior appointments at The Urology Foundation

7 March 2022 | Recruitment & Personnel
The Urology Foundation (TUF) has appointed Rebecca Porta as Chief Executive. An established and experienced charity Chief Executive, Rebecca brings a wealth of experience having held senior roles within some of the UK’s leading health and medical research charities.

ABC UK announces 2025 Nurse of the Year – Kathryn Chatterton

9 September 2025
Action Bladder Cancer UK (ABC UK) is delighted to announce that the winner of the 2025 ABC UK Nurse of the Year award is Kathryn Chatterton, Bladder Cancer Advanced Nurse Practitioner / Cancer Nurse Specialist at Guy’s and St Thomas’...

The Future of Prostate Cancer Imaging: What’s Next?

7 January 2026
The pioneering charity Prostate Cancer Research convened industry leaders, NHS experts and patients for a webinar exploring how artificial intelligence (AI) is transforming prostate cancer imaging and clinical pathways. The session provided valuable insights for healthcare professionals seeking innovative approaches...

EBM Stats Calc: there’s a stat for that

1 November 2018 | | URO - Basic Science Research, URO - Technology
Quantifying the value of a specific test or intervention for a patient is no easy feat. Even when the value of a given test or intervention has been established, there may be additional case-specific factors to consider that are not...